| Non-Hodgkin Lymphoma (NHL) |
1 |
0.97 |
| Food and Drug Administration (FDA) |
0 |
0.67 |
| Lymphoma |
0 |
0.67 |
| Follicular Lymphoma |
0 |
0.59 |
| Chronic Lymphocytic Leukemia |
0 |
0.28 |
| Clinical Research |
0 |
0.17 |
| Healthcare and Medical Technology |
0 |
0.17 |
| Refractory |
0 |
0.17 |
| Cancer |
0 |
0.08 |
| Complementary and Alternative Medicine |
0 |
0.08 |
| Dorsum |
0 |
0.08 |
| Drug and Treatment Safety |
0 |
0.08 |
| Leukemia |
0 |
0.08 |
| Patient Safety |
0 |
0.08 |